Sun Pharmaceutical Industries has secured a major win after the Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal granted Sun Pharma CESTAT relief by setting aside a Rs 39 crore excise duty demand raised by tax authorities...
Hindustan Laboratories has filed IPO papers with SEBI, preparing for its market debut and signaling a strategic move to expand operations in India’s fast?growing generic drug market. The submission is made at a time when there is still a high...
The World Health Organization (WHO) has prequalified two rapid antigen test diagnostics (Ag-RDTs) for SARS-CoV-2 infections. This is historic, as Ag-RDTs are now prequalified for use for the first time.
Practo, a digital healthcare platform, plans to hit $1 billion in yearly gross merchandise value (GMV) by June 2026.
Merck has revealed a historic deal with the American government meant to increase prescription drug access for American consumers while simultaneously lowering costs.
The Most Favoured Nation (MFN) drug pricing policy proposed in the United States is not expected to have an immediate impact on Indian pharmaceutical companies, according to industry analysts and market experts. The policy seeks to align US prescr...
Lupin Limited, a global pharma company, announced today that the Committee for Medicinal Products to Human Use (CHMP) of the European Medicines Agency had given a positive opinion. The opinion suggests that Lupin marketing authorization be...
AstraZeneca and Daiichi Sankyo received FDA approval for Enhertu as a first?line therapy for HER2-positive metastatic breast cancer, altering treatment for newly diagnosed patients.The ruling will allow the use of Enhertu with Perjeta developed...
Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd & CEO, Venus Medicine Research Centre, engaged in a conversation with Thiruamuthan, Assistant Editor at India Pharma Outlook, discusses how India is working to improve rare diseas
Alembic Pharmaceuticals has received final FDA approval for its Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, a generic version of the branded eye treatment Zylet. This achievement enhances the pipeline of U.S. generics at the...